설명

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

More Figures from This Paper

Figure 8

Correlation analysis between gut microbiota changes and hepatic inflammation markers in berberine-treated mice with autoimmune hepatitis.

chart

Figure 11

Supplementary experimental data (panel 11) from the berberine autoimmune hepatitis study, providing additional evidence of gut microbiota modulation and hepatoprotective effects in the concanavalin A mouse model.

chart

Figure 17

Graphical summary of berberine's mechanism of action in alleviating concanavalin A-induced autoimmune hepatitis in mice, highlighting its role in modulating the gut microbiota and restoring intestinal barrier integrity.

diagram

Figure 18

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart

Figure 19

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart

Figure 20

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart

Figure 29

Chart

863 × 337px · 155.7 KB

Source Paper

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.

Hepatology communications (2024)

PMID: 38466881

DOI: 10.1097/HC9.0000000000000381

Cite This Figure

![Figure 29: Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.](https://pdfs.citedhealth.com/figures/38466881/753.png)

> Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." *Hepatology communications*, 2024. PMID: [38466881](https://pubmed.ncbi.nlm.nih.gov/38466881/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/38466881/753.png" alt="Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications." />
  <figcaption>Figure 29. Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.<br>  Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." <em>Hepatology communications</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38466881/">38466881</a></figcaption>
</figure>

설명

More Figures from This Paper

Figure 29

Source Paper

Cite This Figure

관련 근거